141 related articles for article (PubMed ID: 20501787)
1. New US law applies 'sunshine' to physician payments and gifts from drug, device industries.
Woodward C
CMAJ; 2010 Jul; 182(10):E467-8. PubMed ID: 20501787
[No Abstract] [Full Text] [Related]
2. Doctors face compulsory system to declare gifts and hospitality from drug companies.
O'Dowd A
BMJ; 2015 Aug; 351():h4617. PubMed ID: 26311722
[No Abstract] [Full Text] [Related]
3. The Physician Payments Sunshine Act: Implications and Predictions.
Litman RS
Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29363562
[No Abstract] [Full Text] [Related]
4. Two years of sunshine: has openness about payments reduced industry influence in healthcare?
Lenzer J
BMJ; 2016 Aug; 354():i4608. PubMed ID: 27562781
[No Abstract] [Full Text] [Related]
5. Brightening up: the effect of the Physician Payment Sunshine Act on existing regulation of pharmaceutical marketing.
Gorlach I; Pham-Kanter G
J Law Med Ethics; 2013; 41(1):315-22. PubMed ID: 23581674
[TBL] [Abstract][Full Text] [Related]
6. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
Lee J
Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407
[No Abstract] [Full Text] [Related]
7. Drug companies will have to report all payments to US doctors from March 2014.
Roehr B
BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117
[No Abstract] [Full Text] [Related]
8. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
Rosenthal MB; Mello MM
N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
[No Abstract] [Full Text] [Related]
9. Letting the sunshine in: shining a new light on physician-industry relationships.
Bruguera CM; Hirsch JA
J Neurointerv Surg; 2010 Mar; 2(1):80-2. PubMed ID: 21990565
[TBL] [Abstract][Full Text] [Related]
10. Already feeling the heat: Docs rethinking payments as Sunshine Act looms.
Lee J
Mod Healthc; 2013 Jul; 43(26):12-3. PubMed ID: 23878901
[No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: business practices.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
[No Abstract] [Full Text] [Related]
12. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
Connors AL
Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
[No Abstract] [Full Text] [Related]
13. Sunshine laws and the pharmaceutical industry.
Brennan TA; Mello MM
JAMA; 2007 Mar; 297(11):1255-7. PubMed ID: 17374820
[No Abstract] [Full Text] [Related]
14. The Sunshine Act: how to avoid getting burned.
Hurd P
Fam Pract Manag; 2013; 20(5):8-10. PubMed ID: 24134101
[No Abstract] [Full Text] [Related]
15. Can India stop drug companies giving gifts to doctors?
Mukherjee R
BMJ; 2013 Apr; 346():f2635. PubMed ID: 23628750
[No Abstract] [Full Text] [Related]
16. French "sunshine act" sheds little light on drug industry's payments to doctors, say critics.
Benkimoun P
BMJ; 2013 Jun; 346():f3762. PubMed ID: 23757751
[No Abstract] [Full Text] [Related]
17. The Sunshine Act--effects on physicians.
Agrawal S; Brennan N; Budetti P
N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163
[No Abstract] [Full Text] [Related]
18. Shining a light on the Sunshine Act.
Peck AA
J Med Assoc Ga; 2013; 102(2):28. PubMed ID: 24006732
[No Abstract] [Full Text] [Related]
19. Transparency of industry payments needed in clinical practice guidelines.
Vassar M; Bibens M; Wayant C
BMJ Evid Based Med; 2019 Feb; 24(1):8-9. PubMed ID: 30042209
[No Abstract] [Full Text] [Related]
20. An Analysis of the Open Payment Database in Neurotology.
Ziai K; Sahyouni R; Moshtaghi O; Vu K; Goshtasbi K; Ghavami Y; Lee L; Lin HW; Djalilian HR
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):319-322. PubMed ID: 29389305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
